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OBJECTIVE—Impairments in mitochondrial physiology may
play a role in diabetic sensory neuropathy. We tested the
hypothesis that mitochondrial dysfunction in sensory neurons is
due to abnormal mitochondrial respiratory function.
RESEARCH DESIGN AND METHODS—Rates of oxygen con-
sumption were measured in mitochondria from dorsal root
ganglia (DRG) of 12- to- 22-week streptozotocin (STZ)-induced
diabetic rats, diabetic rats treated with insulin, and age-matched
controls. Activities and expression of components of mitochon-
drial complexes and reactive oxygen species (ROS) were
analyzed.
RESULTS—Rates of coupled respiration with pyruvate 
malate (P  M) and with ascorbate  TMPD (Asc  TMPD) in
DRG were unchanged after 12 weeks of diabetes. By 22 weeks of
diabetes, respiration with P  M was signiﬁcantly decreased by
31–44% and with Asc  TMPD by 29–39% compared with
control. Attenuated mitochondrial respiratory activity of STZ-
diabetic rats was signiﬁcantly improved by insulin that did not
correct other indices of diabetes. Activities of mitochondrial
complexes I and IV and the Krebs cycle enzyme, citrate synthase,
were decreased in mitochondria from DRG of 22-week STZ-
diabetic rats compared with control. ROS levels in perikarya of
DRG neurons were not altered by diabetes, but ROS generation
from mitochondria treated with antimycin A was diminished
compared with control. Reduced mitochondrial respiratory func-
tion was associated with downregulation of expression of mito-
chondrial proteins.
CONCLUSIONS—Mitochondrial dysfunction in sensory neu-
rons from type 1 diabetic rats is associated with impaired rates of
respiratory activity and occurs without a signiﬁcant rise in
perikaryal ROS. Diabetes 59:1082–1091, 2010
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eripheral nerves of diabetic patients develop a
spectrum of pathology that can take many years
to emerge (1,2). Experimental studies over
shorter time periods have demonstrated that
hyperglycemia can induce cellular damage through in-
creased glucose metabolism by aldose reductase (3), ele-
vated protein glycation (4), and increased mitochondrial
NADH supply, which enhances electron availability caus-
ing partial reduction of oxygen to superoxide radicals in
the proximal part of the electron transport chain (5,6).
These three mechanisms may combine to trigger large
elevations in reactive oxygen species (ROS) that induce
oxidative stress and tissue damage (7–9). The ability of
nerves to survive oxidative stress may also be impaired in
diabetes because of suboptimal trophic support from
insulin, insulin-like growth factors, and neurotrophic fac-
tors (10,11).
Although increased oxidative stress has become a
widely accepted consequence of hyperglycemia in models
of diabetic neuropathy, the source of excessive ROS is not
deﬁned. Mitochondria are one plausible source of ROS,
based on reports of an acute glucose-induced elevation of
ﬂux through the electron transport chain in endothelial
cells that was accompanied by hyperpolarization of the
mitochondrial inner membrane and subsequent stimula-
tion of ROS generation in the proximal aspect of the
electron transport chain (5,6). However, this mechanism
may not extend to other cell types or to longer durations of
diabetes, since mitochondrial respiration and enzymatic
activities are reduced in mitochondria from streptozotocin
(STZ)-induced diabetic rat hearts (12,13), and activity of
the mitochondrial electron transport chain and citrate
synthase are decreased in skeletal muscle of patients with
type 2 diabetes (14–16). Further, we and others have
measured depolarization, rather than hyperpolarization, of
the mitochondrial inner membrane in acutely isolated
adult DRG sensory neurons from STZ-diabetic rats that
can be corrected by treatment with neurotrophin-3 or
insulin at doses that did not affect hyperglycemia (17–19).
Given the unclear understanding of the contribution of
mitochondrial-derived ROS to neuronal oxidative stress,
we have now directly measured rates of activity within the
mitochondrial respiratory chain and ROS production in
neurons from STZ-diabetic rats.
RESEARCH DESIGN AND METHODS
Induction, treatment, and conﬁrmation of type 1 diabetes. Male
Sprague-Dawley rats were made diabetic with a single intraperitoneal injec-
tion of 75 mg/kg STZ (Sigma, St. Louis, MO). These diabetic rats were healthy
and did not need insulin supplementation to maintain body weight. Insulin
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placed subcutaneously into a subgroup of STZ-diabetic rats after 18 weeks of
diabetes and remained in place for a further 4 weeks to test the impact of
suboptimal insulin levels on mitochondrial function. Animals were killed and
tissue collected after 12, 16, or 22 weeks of diabetes. Animal procedures
followed guidelines laid down by the University of Manitoba Animal Care
Committee using the Canadian Council of Animal Care guidelines. Nonfasting
blood glucose concentration was measured using the Accu-Chek Compact
Plus glucometer (Roche, Laval, QC, Canada) and blood A1C levels by the
A1cNow system (Bayer Healthcare, Sunnyvale, CA). Nerve sugar and polyol
content was measured by gas chromatography of trimethylsilyl derivatives
(17) and lipid peroxidation by spectrophotometric assay of total malondial-
dehyde (MDA) and 4-hydroxyalkanal (HAE) content (LPO-586 kit, Oxis, CA)
(20).
Preparation of tissue homogenates and isolated mitochondria from
lumbar DRG. Cohorts 1, 2, and 3 (Table 1) were used to prepare lumbar DRG
tissue homogenates for mitochondrial respirometry, and another group (co-
hort 4) was used as a source of mitochondrial preparations from lumbar DRG.
Lumbar DRG were rinsed in ice-cold solution containing sucrose/Tris/EDTA
(STE) buffer (250 mmol/l sucrose, 10 mmol/l Tris-HCl, 1 mmol/l EDTA, pH 7.4)
and then homogenized with a polytron homogenizer (Kinematica, Lucerne,
Switzerland) using 3  7.5 s grinding pulses at 30-s intervals. In cohort 4,
mitochondria were isolated from lumbar DRG using a differential centrifuga-
tion method (21). The protein content was measured according to the method
of Bradford. The degree of integrity of the mitochondrial preparation was
tested by adding exogenous cytochrome c (10 mol/l) in the presence of
pyruvate, malate, and ADP. Under these conditions, the respiration rate in
lumbar DRG was increased by 17  8% in control and 22  9% in 22 weeks
STZ-diabetic rats (means  SD, n  4). This demonstrates a low level of
fragmentation of the mitochondria and the similarity of the preparation
between the two groups.
Western blotting for mitochondrial proteins. Mitochondrial preparations
were homogenized in STE buffer and 5–10 g protein resolved on a 10%
SDS-PAGE gel and electroblotted onto nitrocellulose membrane. Blots were
then blocked in 5% nonfat milk containing 0.05% Tween-20, rinsed in PBS (pH
7.4), and incubated with the following antibodies: monoclonal anti–cyto-
chrome c oxidase subunit 4 (COX IV, 1:1,000; MitoSciences, Eugene, OR),
monoclonal anti-NADH dehydrogenase (ubiquinone) iron-sulfur protein 3
(NDUFS3, 1:1,000; MitoSciences), and monoclonal anti-ATP synthase  sub-
unit (1:2,000 dilution; MitoSciences). Extracellular signal–regulated kinase
(ERK, 1:2,000; Covance) was probed as a loading control (previous studies
show this protein to not change level of expression in DRG in diabetes). The
blots were rinsed, incubated in Western blotting Luminol Reagent (Santa Cruz
Biotechnology), and imaged using a Bio-Rad Fluor-S image analyzer (Bio-Rad,
Hercules, CA).
Mitochondrial respiration assay. Oxygen consumption was determined at
37°C using the OROBOROS Oxygraph-2K (OROBOROS Instruments, Inns-
bruck, Austria) (22). Tissue homogenates or isolated mitochondria from
lumbar DRG were resuspended in KCl medium (80 mmol/l KCl, 10 mmol/l
Tris-HCl, 3 mmol/l MgCl2, 1 mmol/l EDTA, 5 mmol/l potassium phosphate, pH
7.4). Various substrates and inhibitors for mitochondrial respiratory chain
complexes were used as described in Fig. 1. OROBOROS DatLab software was
used to calculate the oxygen consumption.
Determination of enzymatic activities of mitochondrial complexes and
citrate synthase. All measurements of enzymatic activities in lumbar DRG
mitochondrial preparations were performed spectrophotometrically using a
temperature-controlled Ultrospec 2100 ultraviolet-visible spectrophotometer
(Biopharmacia Biotech, Uppsala, Sweden). Complex I activity was measured
as rotenone-sensitive NADH:cytochrome c reductase activity. Puriﬁed mito-
chondria were thawed and subjected to three freeze-thaw cycles to disrupt
mitochondrial membranes and permit access of substrates. Freshly prepared
assay buffer (50 mmol/l K-phosphate, pH 7.4, 1 mmol/l potassium cyanide
(KCN), 100 mol/l NADH) and 10 g protein of mitochondrial preparation
were added to the cuvette and preincubated for 3 min at 25°C. After addition
of 100 mol/l oxidized cytochrome c, the reaction was followed for 2 min at
550 nm and then for 2 more minutes after addition of 25 mol/l rotenone to
allow calculation of the rotenone-sensitive complex I activity. Complex IV
activity was measured at 25°C by monitoring the absorbance decrease of
reduced cytochrome c at 550 nm (23). The reaction was started by addition of
40 mo/l reduced cytochrome c into 50 mmol/l phosphate buffer containing 5
g mitochondrial protein solubilized with 0.02% laurylmaltoside. Activity of
the Krebs cycle enzyme, citrate synthase, was determined at 25°C in medium
containing 150 mmol/l Tris-HCl (pH 8.2), 0.02% laurylmaltoside, 0.1 mmol/l
dithionitrobenzoic acid, and 5 g mitochondrial protein (24). The reaction was
initiated by addition of 100 mol/l acetyl CoA and changes in absorbance at
412 nm were measured for 1 min. This value was subtracted from the rate
obtained after addition of 0.05 mmol/l oxaloacetic acid.
Analysis of ROS measurement in adult sensory neurons. Adult lumbar
DRG sensory neuron cultures from age-matched control and 22-week STZ-
diabetic rats were prepared as described previously (17). Neurons were
suspended in modiﬁed Bottenstein and Sato’s N2 medium (0.1 mg/ml trans-
ferrin, 20 nmol/l progesterone, 100 mol/l putrescine, 30 nmol/l sodium
selenite, and 1 mg/ml BSA, 0.01 mmol/l cytosine arabinoside; all from Sigma)
in Ham’s F12. To mimic in vivo conditions, the following additions were made
to the basal deﬁned medium: control 10 nmol/l insulin and diabetic 25 mmol/l
glucose. ROS levels were imaged on a Carl Zeiss LSM510 inverted confocal
microscope using two dyes: dihydrorhodamine 123 (DHR123) or 5-(and-6)-
chlromethyl-27-dichlorohydroﬂuorescein diacetate acetyl ester (CM-
H2DCFDA). Neurons were loaded with 5 mol/l DHR 123 (Sigma, in 100%
stock solution) or 1.2 mol/l CM-H2DCFDA (Invitrogen, Carlsbad, CA) for 30
or 15 min, respectively, at 37°C. For DHR 123 and CM-H2DCFDA, excitation/
emission was 488/505 nm.
Measurement of ROS in mitochondrial preparations from lumbar DRG.
ROS generation in lumbar DRG mitochondria from control and 22-week
STZ-diabetic rats was evaluated by the detection of H2O2. Hydrogen peroxide
production was determined ﬂuorometrically by measuring oxidation of Am-
plex Red (Invitrogen) (22). Fluorescence of the Amplex Red oxidation
product was measured at 25°C using SpectraMax Gemini spectroﬂuorometer
(Molecular Devices, Sunnyvale, CA). Excitation/emission wavelengths were
530/590 nm. The assay was performed with 100 g mitochondrial protein per
TABLE 1
Rat body weight, blood glucose levels, and glycated hemoglobin at end point
n Weight (g) Blood glucose (mmol/l) A1C (%)
Cohort 1 (12 weeks)
Control 5 603.7  38.8**** 8.14  1.52**** 4.34  0.24****
Diabetic 5 280.4  16.5 28.16  3.53 7.70  0.78
Cohort 2 (16 weeks)
Control 11 679.4  25.3**** 8.80  2.34**** 4.76  0.21****
Diabetic 7 367.7  42.5 31.09  2.96 8.90  0.73
Cohort 3 (22 weeks)
Control 6 756.17  70.03* 8.25  0.85* 3.48  0.10*
Diabetic 6 413.25  64.30 30.72  1.65 7.76  0.77
Diabetic  insulin 6 498.97  24.02*** 20.37  11.11*** 7.32  0.61
Cohort 4 (22 weeks)
Control 12 782.73  107.39* 8.29  1.58* 4.65  0.38*
Diabetic 12 390.13  43.72 29.03  2.63 10.68  1.04
Diabetic  insulin 12 493.30  50.38** 20.23  6.85 9.10  0.65**
Starting body weight ranged between 275 and 325 g. Cohorts were maintained for 12–22 weeks. Rats from cohort 3 and 4 were used for the
preparation of lumbar DRG tissue homogenate samples and isolated mitochondria samples from lumbar DRG, respectively. Values are
means  SD. *P 	 0.05 vs. other groups; **P 	 0.001 vs. diabetic; ***P 	 0.05 vs. diabetic (all by one-way ANOVA with Tukey’s post hoc test);
and **** P 	 0.0001 vs. diabetic (Student’s t test). Note that %A1C values in cohort 3 were derived using the DCA 2000  kit (n  4–5) and
for cohort 4 were generated using the A1C Now kit (n  8–11).
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mmol/l malate in the presence or absence of antimycin A (10 g/ml). Amplex
red was used at 50 mol/l, with horseradish peroxidase at 0.5 units/ml.
Nerve structure and function. Function of small sensory neurons was
inferred by measuring hind paw thermal response latency using a modiﬁed
Hargreaves apparatus (University Anesthesia Research and Development, San
Diego, CA) with a heating rate of 
1°C/s from a baseline of 30°C and with a
cutoff at 20 s (25). The structural integrity of small sensory neurons was
assessed by measuring intraepidermal nerve ﬁber (IENF) proﬁles in hind paw
plantar skin that was immersion ﬁxed in 4% paraformaldehyde and processed
to parafﬁn blocks. Sections (6 m) were stained with the pan-neuronal marker
PGP9.5 (1:1,000; Biogenesis, U.K.) and viewed under a light microscope to
allow counting of IENF and subepidermal nerve proﬁles per unit length of
the dermal:epidermal border (26). Structural integrity of large myelinated
ﬁbers was assessed by measuring mean axonal caliber in distal tibial
nerves that were immersion ﬁxed in 2.5% glutaraldehyde, postﬁxed in
osmium tetroxide, and processed to araldite blocks before cutting 1.0-m
sections. Tissue sections were stained with p-phenylenediamine and
viewed under a light microscope connected to a computer running image
analysis software to allow calculation of axonal diameter (17).
Data analysis. Where appropriate, data were subjected to one-way ANOVA with
post hoc comparison using Tukey’s test or two-way ANOVA with Bonferroni’s
A
B
C
FIG. 1. Representative measurements of oxygen consumption in isolated lumbar DRG mitochondria from control, diabetic, and insulin-treated
diabetic rats. Freshly isolated lumbar DRG mitochondria were assessed in control (A), diabetic (B), and insulin-treated (C) diabetic rats using
OROBOROS oxygraph 2K as described in RESEARCH DESIGN AND METHODS. Thick lines indicate the level of oxygen in the chamber of electrode and
expressed in nanomoles per milliliter. Thin lines indicate oxygen ﬂux per mass (picomoles O2 per second per milligram protein) in the presence
of speciﬁc substrates and inhibitors of the mitochondrial respiratory chain. L-DRG, lumbar dorsal root ganglia mitochondria; P, pyruvate (10
mmol/l); M, malate (5 mmol/l); ADP, adenosine diphosphate (2 mmol/l); Ol, oligomycin (1.0 mol/l); FCCP, carbonyl cyanide 4-triﬂuoromethoxy-
phenylhydrazone (0.5 mol/l); AA, antimycin A (1 g/ml); Asc, ascorbate (5 mmol/l); TMPD, N,N,N,N-tetramethyl-p-phenylenediamine
dihydrochloride (0.5 mmol/l); KCN, potassium cyanide (0.25 mmol/l).
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other cases, standard two-tailed Student’s t test was performed.
RESULTS
STZ-diabetic rats did not suffer weight loss during the
study but showed reduced weight gain after 12–22 weeks
of STZ-induced diabetes compared with age-matched con-
trols (Table 1). Persistence of diabetes was also indicated
by elevated nonfasting blood glucose and glycated hemo-
globin levels (Table 1). STZ-diabetic rats of cohorts 3 and
4 that received insulin supplementation for the ﬁnal 4
weeks of a 22-week period of diabetes showed a partial
recovery of body weight accompanied by a partial de-
crease in blood glucose, but retained elevated glycated
hemoglobin levels. Insulin treatment also partially lowered
nerve glucose content and corrected the deﬁcit in myo-
inositol (Table 2). Diabetes-induced increases in nerve
fructose content and lipid peroxidation were not altered
by insulin therapy. Nerve protein content was not altered
by diabetes, whereas insulin treatment signiﬁcantly in-
creased this parameter above in both controls and un-
treated diabetic rats.
There was no overt evidence of degeneration in the
distal tibial nerve of rats after 22 weeks of diabetes
(supplemental Fig. 1A and , available in an online appen-
dix at http://diabetes.diabetesjournals.org/cgi/content/full/
db09-1299/DC1), and morphometric analysis indicated a
mild trend toward decreased mean axonal diameter asso-
ciated with a shift in the size-frequency distribution to-
ward smaller ﬁbers (supplemental Fig. 1C and D). Paw
thermal response latency was normal in rats after 22
weeks of diabetes, as were both IENF and subepidermal
nerve proﬁle counts (supplemental Fig. 2A–D). Insulin
supplementation for the last 4 weeks of diabetes signiﬁ-
cantly increased paw IENF proﬁle number compared with
controls (supplemental Fig. 2D).
Mitochondrial respiratory chain activity of DRG was
determined using a Clarke type electrode in the presence
of speciﬁc substrates and inhibitors of the mitochondrial
respiratory chain. Figure 1 demonstrates typical measure-
ments of oxygen consumption in freshly isolated mito-
chondria of lumbar DRG from age-matched control,
diabetic, and insulin-treated diabetic rats. Basal respira-
tion in lumbar DRG mitochondria is stated as respiration
at state 4 with energetic substrates, pyruvate and malate
(P  M). Coupled respiration at state 3 was induced by
addition of ADP. After this measurement, the ATP-syn-
thase speciﬁc inhibitor, oligomycin (Ol), was added to
prevent reverse pumping of protons by the ATPase, and
then the uncoupled rate was determined by adding the
uncoupling agent, carbonylcyanide p-triﬂuoromethoxy-
phenylhydrazone (FCCP). Uncoupled respiration was in-
hibited at complex III by antimycin A. Ascorbate (Asc) and
N,N,N,N-tetramethyl-p-phenylenediamine (TMPD) were
then added to determine the capacity of cytochrome c
oxidase (complex IV). TMPD is an artiﬁcial redox media-
tor that assists transfer of electrons from ascorbate to
cytochrome c. Complex IV respiration was calculated as
FIG. 2. Effect of 12–22 weeks of STZ-induced diabetes on the activity of
the mitochondrial respiratory chain in freshly prepared lumbar DRG
tissue homogenate. Measurements of oxygen consumption were per-
formed with energetic substrates, pyruvate and malate, as described in
Fig. 1. Basal respiration (A), pyruvate malate ADP (coupled oxidative
phosphorylation) (B), and the respiration rate with Asc  TMPD (com-
plex IV) (C) were assessed in age-matched controls (Ctrl), STZ-diabetic
rats (Db), and STZ-diabetic rats with insulin implant (Db  Ins) at 12
(n  5), 16 (n  7–11), and 22 (n  5–6) weeks of diabetes. Values are
means  SD; n  as indicated. *P < 0.05 vs. Db  Ins; **P < 0.001 vs. Db
(one-way ANOVA with Tukey’s post hoc comparison).
TABLE 2
Sugar, protein, and lipid peroxidation levels in sciatic nerve
Glucose (nmol/mg)
dry weight
Fructose (nmol/mg)
dry weight
myo-Inositol (nmol/mg)
dry weight
Total
protein (mg/cm)
MDA  HAE (nM/mg)
wet weight
Control Nd Nd 13.24  3.05 1.10  0.24** 12.67  2.36
Diabetic 33.3  9.66** 8.89  6.08 7.94  1.24* 0.98  0.23** 17.35  0.79*
Diabetic  Ins 16.98  8.37 7.55  3.73 11.2  5.8 1.42  0.40* 16.59  3.81*
Sciatic nerves were taken from cohort 4. Values are means  SD (n  6–9). *P 	 0.05 vs. control; **P 	 0.05 vs. diabetic  insulin. Sorbitol
levels were too low to detect in all samples. Nd  nondetectable.
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chrome c oxidase.
Basal respiration with pyruvate and malate (P  M),
rates of coupled respiration at state 3, and the respiration
rate with ascorbate and TMPD (Asc  TMPD; complex IV)
of lumbar DRG tissue homogenates from control and
STZ-diabetic rats were not changed after 12 weeks of
diabetes (Fig. 2). After 16 weeks of diabetes, there was a
statistically nonsigniﬁcant decrease in coupled respiration
and the respiration rate with Asc  TMPD in STZ-diabetic
rats. With progression of untreated diabetes to 22 weeks in
both lumbar DRG tissue homogenates (Fig. 2B) and iso-
lated mitochondria from lumbar DRG (Fig. 3B), coupled
respiration with P  M was decreased by 31–44% in
diabetic rats compared with control lumbar DRG tissue.
This attenuated mitochondrial respiratory activity was
signiﬁcantly improved by 4 weeks of insulin treatment.
Respiration rates with Asc  TMPD were decreased by
29–39% in diabetic lumbar DRG tissues and mitochondrial
preparations and protected by insulin (Figs. 2C and 3D).
Uncoupled respiration in mitochondria isolated from lum-
bar DRG was also decreased in STZ-diabetic rats com-
pared with control and signiﬁcantly improved by insulin
supplementation (Fig. 3C). These deﬁcits were speciﬁc for
lumbar DRG, since similar measurements in cortex re-
vealed no effect after 22 weeks of diabetes (supplemental
Table 1).
Enzymatic activities of mitochondrial complexes and
the Krebs cycle enzyme, citrate synthase, were assessed in
mitochondria isolated from lumbar DRG of age-matched
control and 22-week STZ-diabetic rats. The activity of
mitochondrial complex I was assessed as rotenone-sensi-
tive NADH-cytochrome c reductase when cytochrome c is
the acceptor of electrons. The enzymatic activities of
rotenone-sensitive NADH-cytochrome c reductase (com-
plex I) and cytochrome c oxidase (complex IV) as well as
the Krebs cycle enzyme, citrate synthase, were signiﬁ-
cantly decreased in STZ-diabetic rats compared with con-
trol (Fig. 4).
To determine if decreased mitochondrial activity in
diabetic animals was associated with alterations in ROS
generation, adult sensory neurons from lumbar DRG were
cultured from age-matched control and STZ-diabetic rats
and assessed within2ho fplating for levels of ROS using
the ﬂuorescent dyes DHR 123 and CM-H2DCFDA. Both
dyes provide a broad readout of a range of ROS. Figure
5A–C show that sensory neurons from all treatment
groups exhibited similar levels of DHR 123 ﬂuorescence
emission from perikarya. In a separate group of STZ-
diabetic rats, ROS levels in acutely isolated neurons were
detected using CM-H2DCFDA and conﬁrmed the lack of
any effect of diabetes on ROS generation (Fig. 5D–F). ROS
generation (H2O2 as detected by Amplex red) by mito-
chondria isolated from lumbar DRG of age-matched
FIG. 3. Mitochondrial respiratory chain activity is impaired in freshly isolated mitochondria from lumbar DRG of 22 weeks of STZ-diabetic rats.
After measurement of coupled respiration, the ATP synthase speciﬁc inhibitor, oligomycin, was added to prevent reverse pumping of protons by
the ATPase, and then the uncoupled rate of mitochondrial respiration was generated by adding the uncoupling agent FCCP. Basal respiration (A),
pyruvate  malate  ADP (coupled oxidative phosphorylation) (B), FCCP (uncoupled respiration) (C), and the respiration rate with Asc 
TMPD (complex IV) (D) were measured in age-matched controls (Ctrl), STZ-diabetic rats (Db), and STZ-diabetic rats with insulin implant (Db 
Ins) after 22 weeks of diabetes. Values are means  SD, n  6. *P < 0.05 vs. other groups; **P < 0.05 vs. Db  Ins (one-way ANOVA with Tukey’s
post hoc comparison). Treatment of the mitochondrial preparation with the uncoupler FCCP induced a four- to sixfold elevation in the rate of
oxygen consumption over the basal rate conﬁrming that the mitochondrial preparations were intact and of high quality in all groups.
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metrically using the Amplex Red kit. ROS generation in
lumbar DRG mitochondria in the presence of the sub-
strates, pyruvate and malate, was not elevated in STZ-
diabetic rats compared with control (Fig. 5G). However,
when mitochondria samples were treated with antimycin
A (a speciﬁc inhibitor of complex III), control rats signif-
icantly increased ROS production compared with age-
matched STZ-diabetic rats (Fig. 5H). Finally, quantitative
Western blotting showed diminished expression of some
components of the mitochondrial electron transport chain
(Fig. 6). NDUFS3 (component of complex I) and COX IV
(component of complex IV) were signiﬁcantly decreased
by 50 and 20%, respectively, whereas levels of ATP syn-
thase -subunit and ERK remained unaltered.
DISCUSSION
In this study, we show, we believe for the ﬁrst time, that
mitochondrial respiratory function, activity, and expres-
sion of components of the respiratory chain and the Krebs
cycle enzyme, citrate synthase, are decreased in DRG
sensory neurons from rats with type 1 diabetes. This novel
observation provides direct functional evidence of diabe-
tes-induced alterations in mitochondrial performance at
multiple sites along the mitochondrial respiratory chain.
Previous studies have used only indirect assessments of
mitochondrial inner-membrane polarization to analyze mi-
tochondrial dysfunction in DRG sensory neurons in diabe-
tes (17–19). Importantly, decreased mitochondrial
respiratory activity was not associated with increased
production of ROS. These observations imply that the
diabetes-induced impairment of mitochondrial function is
not associated with generation of oxidative stress.
Mitochondrial dysfunction has been proposed to medi-
ate development of diabetes complications in endothelial
cells, skeletal muscle, cardiomyocytes, and neurons (12–
14,27). Studies of isolated endothelial cells demonstrate
that a short period of exposure to high glucose concentra-
tions induces hyperpolarization of the mitochondrial inner
membrane, which is a consequence of glycolysis-driven
enhancement of electron donation from the tricarboxylic
acid pathway (5). It was therefore proposed that the high
electrochemical potential difference across the mitochon-
drial membrane, driven by excessive proton gradient,
prolonged the life of superoxide-producing electron trans-
fer intermediates such as ubi-semiquinone (5). However,
recent studies have revealed that respiration and enzy-
matic activities are decreased in mitochondria from hearts
of STZ-diabetic rats (12,13), whereas several studies have
reported decreased activity of the mitochondrial respira-
tory chain and the Krebs cycle enzyme, citrate synthase, in
skeletal muscle of patients with type 2 diabetes (14–16).
Our data are consistent with these ﬁndings and indicate
that decreased rates of respiration and activities of mito-
chondrial complexes and citrate synthase occur in ner-
vous tissues exposed to prolonged diabetes in vivo.
Diminished mitochondrial respiratory function caused
by diabetes has been investigated by proteomic and gene
array techniques (28,29). Reduced expression of oxidative
phosphorylation genes have been found in type 2 diabetes
(30), and decreased expression of the transcriptional
regulator NRF-1 and the transcriptional coactivator perox-
isome proliferator–activated receptor- coactivator 1

(PGC-1
) were observed in pre-diabetic and diabetic mus-
cle (31). These proteins regulate cellular energy metabolism,
including mitochondrial biogenesis and oxidative phosphor-
ylation. Our results showing reduced expression of NDUFS3
and COX IV in Fig. 6 are consistent with these ﬁndings and
support the suggestion that reduced activity of the mitochon-
drial respiratory chain could result from a proteome alter-
ation leading to reduced expression/activity of a range of
mitochondrial components.
Studies in lens (32), retina (33), and cardiac tissue (34)
in experimental animal models of type 1 diabetes show
that parts of glycolytic pathway function are depressed. In
diabetic rats, activity of 6-phosphofructokinase is reduced
in nerve (35), and activity of hexokinase, the ﬁrst rate-
limiting step in glycolysis, is reduced in DRG (36). Dimin-
ished activity of glycolytic pathway enzymes may combine
to reduce delivery of pyruvate and other glucose metabo-
lism-dependent products to the tricarboxylic acid pathway
(32–34,37), and it has been shown that pool sizes of
products of glycolysis, such as pyruvate, are either un-
changed or reduced in diabetes (33,38). It therefore ap-
pears that rates of electron donation to the electron
A
B
C
FIG. 4. Enzymatic activities of mitochondrial respiratory chain and
citrate synthase activity are decreased in isolated mitochondria from
lumbar DRG of STZ-diabetic rats. Enzymatic activity of complex I was
assessed as rotenone-sensitive portion of NADH-cytochrome c reduc-
tase (NCCR) (n  5) (A), cytochrome c oxidase (n  6–7) (B), and
citrate synthase (n  5) (C) and was measured as described in
RESEARCH DESIGN AND METHODS. Values are means  SD, n  as indicated.
*P < 0.05 vs. control (Ctrl) (unpaired Student’s t test). Db, diabetic.
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may predispose to lower rates of mitochondrial respira-
tory chain activity and oxidative phosphorylation. Finally,
a diabetes-induced rise in resting intracellular calcium to
200 nmol/l (39) can trigger elevated mitochondrial Ca
2
buffering by entry of Ca
2 through the Ca
2 uniporter and
other routes, which can cause partial or complete inner
mitochondrial membrane depolarization (27). There is
evidence of aberrant mitochondrial buffering of calcium in
neurons from diabetic rats. Plasma membrane depolariza-
A
D E
B C
F
H G
FIG. 5. ROS were not elevated in acutely isolated DRG sensory neurons or mitochondria from STZ-diabetic rats. A–F: ROS levels were assessed
using real-time ﬂuorescence imaging of DHR 123 or CM-H2DCFDA. A and B: DHR 123 loaded neurons from acutely isolated lumbar DRG neurons
of control or STZ-diabetic rats. Bar  100 m. C: Quantiﬁcation of DHR 123 ﬂuorescence intensities of neurons. Values are means  SEM (n 
50–80 neurons, observed in ﬁve independently assessed control (Ctrl) and diabetic (Db) rats). D and E: CM-H2DCFDA–based ROS imaging of
sensory neurons from control and STZ-diabetic rats. Bar  50 m. F: Quantiﬁcation of DCF ﬂuorescence emission. Values are means  SEM (n 
200–230 neurons, observed in two independently assessed control and diabetic rats). G: ROS generation is not elevated in isolated mitochondria
from lumbar DRG of diabetic rats compared with control. Mitochondrial ROS generation was measured at state 4 with substrates pyruvate and
malate (P  M) in the absence or presence of antimycin A (AA). H2O2 was measured ﬂuorometrically in 0.1 mg/ml mitochondrial suspension with
Amplex Red kits (50 mol/l Amplex Red and 0.5 units/ml horseradish peroxidase). Values are mean with n  5. H: Fluorescence intensity at 180
min. Signiﬁcance level was determined by two-way ANOVA with Bonferroni’s post hoc tests. **P < 0.01 for control (P  M) vs. control (P  M 
AA). (A high-quality color representation of this ﬁgure is available in the online issue.)
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2 transients are prolonged in diabetic
neurons and blockade of mitochondrial uptake of Ca
2
using the mitochondrial uncoupler, CCCP, prevented these
abnormalities (40). This implies, indirectly, that abnormal
mitochondrial buffering of Ca
2 plays a role in shaping
Ca
2 transients in diabetic neurons.
In our present study, impaired mitochondrial respira-
tory chain activity was not accompanied by increased ROS
production in neuronal perikarya from STZ-diabetic rats,
whereas generation of ROS in mitochondria from STZ-
diabetic rats treated with pyruvate and malate in the
presence of antimycin A was signiﬁcantly decreased com-
pared with control. In contrast, studies using cultures of
embryonic sensory neurons showed that a high concen-
tration of glucose directly triggers oxidative stress and
apoptosis (8), suggesting differences in ROS production or
management between embryonic and adult neurons in
culture. We have recently found that ROS levels and
adducts of 4-hydroxy-2-nonenal are elevated in the pres-
ence of high glucose in axons of adult sensory neurons
isolated from 3- to 5-month STZ-diabetic rats, with the
perikarya being unaffected (41). Oxidative damage to
lipids in the sciatic nerve was increased in the present
study, supporting previous work (9,42,43). These results
suggest that mitochondrial function may differ between
axons and perikarya or that oxidative stress in axons and
other cells of the nerve trunk may derive from alternative
sources.
Our studies were performed in rats that showed rela-
tively mild STZ-induced diabetes, as indicated by mainte-
nance of starting body weight over a long period of time.
Marked hyperglycemia and increased A1C indicate that
these rats were clearly diabetic and established biochem-
ical consequences of hyperglycemia such as nerve polyol
pathway ﬂux (indicated by nerve fructose accumulation)
and lipid peroxidation were present. This model contrasts
with the acute and extreme STZ-induced insulin-deﬁcient
diabetes frequently studied in rats and mice that may not
adequately model long-term diabetes in well-managed
patients. The absence of signiﬁcantly reduced axonal
caliber in myelinated ﬁbers, altered thermal nociception,
or loss of IENF after 22 weeks of diabetes conﬁrms that
STZ lacked direct neurotoxic effects and emphasizes the
relatively mild nature of the diabetes in our rats, since all
of these disorders have been widely reported in previous
STZ-diabetic rodent studies. We do not suspect a lack of
discrimination in our assays, as we have previously re-
ported reduced axonal caliber (44), thermal hypoalgesia
(25), and IENF loss (26) in STZ-diabetic rodents. Given
that the rats in our present study showed marked hyper-
glycemia, polyol pathway ﬂux, and lipid peroxidation, the
data may suggest that additional risk factors may be
required in concert with these established biochemical
disorders to generate the indices of neuropathy described
above.
Mitochondrial dysfunction appeared only after 16 weeks
of diabetes and therefore represents a metabolic disorder
of neurons that can emerge before onset of functional and
structural manifestations of diabetic neuropathy. Interest-
ingly, abnormalities in calcium homeostasis also appear
after 8–12 weeks of diabetes and could possibly preempt
mitochondrial dysfunction (39). The pathogenesis of this
mitochondrial disorder may involve insulin deﬁciency per
se, since our insulin treatment regime for the last month of
diabetes had minimal effects on indices of systemic diabe-
tes such as body weight, plasma, nerve sugar levels, lipid
peroxidation, and A1C, but had marked effects on mito-
chondrial dysfunction. These ﬁndings agree with prior
reports that insulin has direct effects on mitochondrial
function (17,45). Insulin treatment also increased nerve
total protein and IENF values above those of age-matched
control rats, which may reﬂect the capacity of insulin to
induce sensory neuron axonal sprouting (46,47). The con-
tribution of impaired insulin signaling to complications of
FIG. 6. Expression of components of the electron transport chain are reduced in DRG from STZ-diabetic rats. Shown are representative blots
(A–D) and charts in which NDUFS3 (E), COX IV (F), and ATP synthase  subunit signal (G) have been presented relative to total ERK level.
Values are the means  SEM, n  6. **P < 0.005 vs. control (CTR), *P < 0.05 vs. Db  INS (one-way ANOVA with Tukey’s post hoc test). Db,
diabetic; Db  INS, diabetic with insulin implant.
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in concert with, hyperglycemia is clearly an area of
emerging interest that deserves further study (11,46–48).
In conclusion, our data show that mitochondrial respi-
ratory chain function and activity/expression of mitochon-
drial complexes as well as the Krebs cycle enzyme, citrate
synthase, are decreased in mitochondria isolated from
DRG of STZ-diabetic rats and can be normalized by insulin
at levels that do not markedly alter the consequences of
hyperglycemia. This decreased mitochondrial function
does not induce ROS formation. The appearance of mito-
chondrial dysfunction at a time before onset of overt
functional or structural neuropathy indicates the possibil-
ity of a pathogenic role for insulin deﬁciency in diabetic
neuropathy that is independent of hyperglycemia.
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